Guided Therapeutics, Inc. GTHP
0.11 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.10 Day range 0.138
0.10 52-week range 0.54
- YTD
- -79.63%
- 1 year
- -56.00%
News
businesswire.com Guided Therapeutics Provides Update on its Cervical Cancer Screening Study with Türkiye's Ministry of Health PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced that its landmark cervical cancer screening study,…
defenseworld.net Guided Therapeutics Inc. (OTCMKTS:GTHP) Shares Shorted: Short Interest Up 55.0% in September Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest…
businesswire.com Guided Therapeutics Reaches Collaborative Agreement with Türkiye's Ministry of Health to Become Primary Screening Test for Cervical Cancer PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that it has reached an agreement with the Ministry of…
gurufocus.com Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor Guided Therapeutics, Inc. (OTC: QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distrib
businesswire.com Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from…
gurufocus.com Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba
businesswire.com Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection…
defenseworld.net Haemonetics (NYSE:HAE) vs. Guided Therapeutics (OTCMKTS:GTHP) Head to Head Review Haemonetics (NYSE: HAE - Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses…
businesswire.com Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection…
defenseworld.net Guided Therapeutics (OTCMKTS:GTHP) Shares Down 12.7% – Time to Sell? Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report)'s stock price fell 12.7% on Monday. The company traded as low as $0.2620 and last traded at $0.2620. 3,800 shares traded hands during mid-day…
businesswire.com Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection…
businesswire.com Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuanshuo…
defenseworld.net Guided Therapeutics (OTCMKTS:GTHP) Trading 25.6% Higher – Here’s What Happened Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report)'s stock price was up 25.6% during trading on Monday. The stock traded as high as $0.25 and last traded at $0.2010. Approximately 3,114 shares…
businesswire.com Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection…
businesswire.com Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd. PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on June 27th that it made its first shipment of…
businesswire.com Guided Therapeutics Receives $100,000 from SMI's Investment Partners to Continue Commercialization Process of LuViva in China PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a $100,000 payment from Shandong…
businesswire.com Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received full payment from its Indonesian…benzinga.com Stocks That Hit 52-Week Lows On Tuesday
businesswire.com Guided Therapeutics Schedules Conference Call to Discuss Third
Quarter 2015 Financial Results NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will…
businesswire.com Guided Therapeutics Schedules Conference Call to Discuss Second
Quarter 2015 Financial Results NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will…
